<DOC>
	<DOC>NCT00093301</DOC>
	<brief_summary>The purpose of the study is to compare the efficacy of levosimendan with that of dobutamine in patients with unstable hemodynamics (shock).</brief_summary>
	<brief_title>Levosimendan Versus Dobutamine in Shock Patients</brief_title>
	<detailed_description />
	<mesh_term>Shock</mesh_term>
	<mesh_term>Shock, Septic</mesh_term>
	<mesh_term>Shock, Cardiogenic</mesh_term>
	<mesh_term>Simendan</mesh_term>
	<mesh_term>Dobutamine</mesh_term>
	<criteria>Reduced left ventricular systolic function Hypotension Anuria or oligouria Less than 18 years old Pregnant Uncorrected valvular stenosis Hypertrophic obstructive cardiomyopathy (HOCM) Third degree AV block</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2004</verification_date>
	<keyword>Shock</keyword>
	<keyword>Levosimendan</keyword>
	<keyword>Inotropes</keyword>
	<keyword>Dobutamine</keyword>
	<keyword>Heart failure</keyword>
	<keyword>Sepsis</keyword>
</DOC>